CLVS : Analysis & Opinions

  1. AstraZeneca's Lynparza Approved in EU for Ovarian Cancer - Analyst ...

    December 19, 2014
    AstraZeneca's (AZN) Lynparza was approved as a monotherapy for the maintenance treatment of adults suffering from ovarian ...
  2. Biotechnology: Some of the Strongest Stocks on Nearly Any Time ...

    September 18, 2013
    Biotechnology is an industry which as has lead the very strong healthcare sector on almost every time frame over the last ...
  3. Biggest Healthcare Sector Movers for July 3, 2012

    July 3, 2012
    The market is doing well so far today. The Nasdaq has moved up 0.7%; the S&P 500 is up 0.7%; and the Dow has risen 0.6%. ...
Trading Center